Literature DB >> 9828843

Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase.

E Borgen1, K Beiske, S Trachsel, J M Nesland, G Kvalheim, T K Herstad, E Schlichting, H Qvist, B Naume.   

Abstract

Detection of isolated tumour cells (TCs) in bone marrow (BM) from epithelial cancer patients by immunocytochemical (ICC) analysis seems to predict future relapse, but the reported percentages of positive BMs among patients with localized cancer show large variations and the number of detected TCs is low. This emphasizes the importance of thoroughly testing the methods in use. This study was performed to clarify to what extent positive staining of haematopoietic cells (HCs) interferes with the ICC detection of epithelial cells in BM. BM mononuclear cells (MNCs) from normal donors and stage I-II breast cancer patients were stained with anti-cytokeratin (CK) and isotype control monoclonal antibodies (MAbs) followed by alkaline phosphatase (AP)-based visualization of immunolabelled cells. In the ICC staining of normal donors by the anti-CK MAbs AE1/AE3 or A45-B/B3, rare immunoreactive cells were detected in 7/20 and 8/19 BMs, respectively. Morphological examination recognized all these cells as typical HCs. In the breast cancer patients (n = 257), anti-CK-positive cells were detected in 26.6 per cent, excluding cells with HC morphology. Using the same morphological criteria, isotype control-positive cells were detected in 5.4 per cent of patients. Some of the false-positive events were further analysed and cells with strong reactivity against the AP enzyme alone were detected. Double ICC staining recognized the majority of these AP directly-reactive cells as CD45-negative and human Ig kappa/lambda-positive, in accordance with the phenotype of mature plasma cells. Morphological evaluation and adequate controls are important to ensure the diagnostic specificity of micrometastases in BM. It is recommended that the number of BM MNCs included in negative controls should equal the number of cells in the diagnostic specimens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9828843     DOI: 10.1002/(SICI)1096-9896(199808)185:4<427::AID-PATH127>3.0.CO;2-7

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  25 in total

Review 1.  The basic pathology of human breast cancer.

Authors:  E Mallon; P Osin; N Nasiri; I Blain; B Howard; B Gusterson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-04       Impact factor: 2.673

2.  Epithelial cells in bone marrow: do they matter?

Authors:  W A Marsman; M Westerterp; N J van Heek; F J ten Kate; J R Izbicki; J J B van Lanschot
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

3.  Investigating the role of hematopoietic stem and progenitor cells in regulating the osteogenic differentiation of mesenchymal stem cells in vitro.

Authors:  Jiehong Liao; Kyle E Hammerick; Grant A Challen; Margaret A Goodell; F Kurtis Kasper; Antonios G Mikos
Journal:  J Orthop Res       Date:  2011-04-14       Impact factor: 3.494

4.  [Prognostic and predictive factors of invasive breast cancer: update 2009].

Authors:  T Decker; D Hungermann; W Böcker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

5.  Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy.

Authors:  J Cantin; H Scarth; M Levine; M Hugi
Journal:  CMAJ       Date:  2001-07-24       Impact factor: 8.262

6.  Methylation profiling with a panel of cancer related genes: association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer.

Authors:  Jo Anders Rønneberg; Thomas Fleischer; Hiroko Kato Solvang; Silje H Nordgard; Hege Edvardsen; Ivan Potapenko; Daniel Nebdal; Christian Daviaud; Ivo Gut; Ida Bukholm; Bjørn Naume; Anne-Lise Børresen-Dale; Jörg Tost; Vessela Kristensen
Journal:  Mol Oncol       Date:  2010-11-25       Impact factor: 6.603

7.  Sensitive fluorescent in situ hybridisation method for the characterisation of breast cancer cells in bone marrow aspirates.

Authors:  A Forus; H K Høifødt; G E Overli; O Myklebost; O Fodstad
Journal:  Mol Pathol       Date:  1999-04

8.  Morphological and immunohistochemical characterization of isolated tumor cells by p53 status in gastrointestinal tumors.

Authors:  C Milsmann; L Füzesi; E Heinmöller; P Krause; C Werner; H Becker; O Horstmann
Journal:  Langenbecks Arch Surg       Date:  2007-09-18       Impact factor: 3.445

9.  Detection of disseminated tumor cells in neuroblastoma: 3 log improvement in sensitivity by automatic immunofluorescence plus FISH (AIPF) analysis compared with classical bone marrow cytology.

Authors:  Gabor Méhes; Andrea Luegmayr; Rosa Kornmüller; Ingeborg M Ambros; Ruth Ladenstein; Helmut Gadner; Peter F Ambros
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients.

Authors:  Sabine Riethdorf; Klaus Pantel
Journal:  Breast Cancer Res       Date:  2009-12-18       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.